Evidence map›Paper›PMID 41284139›Full record

ArticleCurrent diabetes reports2025

Implementation Components of Diabetes Prevention Programs after Gestational Diabetes Mellitus: A Scoping Review.

Katelyn Sushko, Megan Racey, Paige Alliston, Diana Sherifali, Kelly Smith, Lorraine Lipscombe

Abstract readScoping Review
PubMed Publisher
In one paragraph

Article in Current diabetes reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katelyn SushkoWomen's College Research and Innovation Institute, Women's College Hospital, Toronto, ON, Canada. katelyn.sushko@wchospital.ca.ORCID http://orcid.org/0000-0002-8530-6900
Megan RaceySchool of Nursing, McMaster University, Hamilton, ON, Canada.
Paige AllistonSchool of Nursing, McMaster University, Hamilton, ON, Canada.
Diana SherifaliSchool of Nursing, McMaster University, Hamilton, ON, Canada.
Kelly SmithMichael Garron Hospital, Toronto, ON, Canada.
Lorraine LipscombeWomen's College Research and Innovation Institute, Women's College Hospital, Toronto, ON, Canada.

Funding

Transforming Health with Integrated Care (THINC) Implementation Science Team Grant - Health Services and Policy pool Program: In Partnership with the Canadian Institute of Health Research (CIHR) - Institute of Health Services and Policy Research (IHSPR); CIHR - IMHA; CIHR - SPOR grant number 02432 - 000
6 · The paper itself

Abstract

purpose of reviewTo synthesize the components of diabetes prevention programs (DPPs) after gestational diabetes mellitus (GDM) and how they relate to factors that influence implementation. We conducted a scoping review of the literature using MEDLINE, Embase, PsychINFO, and Emcare. We provided a narrative description of intervention components based on the Template for Intervention Description and Replication (TIDieR) and the study results based on the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. RECENT

findingsSeventeen included studies described DPPs after GDM. Recruitment typically began during pregnancy, while interventions started postpartum, with higher reach and participation rates for studies that recruited during pregnancy. The included DPPs used face-to-face delivery, virtual delivery, or a combination. Many programs were individual, but a few had a group component. Program duration varied from one month to three years. The available data highlighted the need to increase engagement, particularly for minority groups, and utilize flexibility and tailoring of program components and delivery to optimize retention, impact and sustainability. Significant barriers to the successful implementation of DPPs after GDM exist; the reporting of intervention components and implementation outcomes in the existing studies is variable. Validated frameworks, including RE-AIM, should be integrated into intervention development, implementation and evaluation.

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 2FemaleHumansPregnancyDiabetesGestational diabetes mellitusPregnancyType 2 diabetes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.